INTEGRASE in Slovenian translation

• integraze
• integraza
• integrazi
• integrazo
• integaze

Examples of using Integrase in English and their translations into Slovenian

The decision to use dolutegravir for such patients should be informed by the integrase resistance pattern(see section 5.1).
Odločitev za uporabo dolutegravirja pri takšnih bolnikih mora temeljiti na podatkih o odpornosti na zaviralce integraze(glejte poglavje 5.1).

Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral Deoxyribonucleic acid(DNA)
Dolutegravir zavira integrazo HIV z vezavo na aktivno mesto integraze in blokira korak prenosa vgradnje sklopa retrovirusne deoksiribonukleinske kisline(DNK),

Dolutegravir inhibits HIV integrase by binding to the integrase active site and blocking the strand transfer step of retroviral Deoxyribonucleic acid(DNA)
Dolutegravir zavira integrazo HIV z vezavo na aktivno mesto integraze in preprečuje prenos zapisa pri vgradnji retrovirusne deoksiribonukleinske kisline(DNK),

All HIV-1 isolates from patients in both treatment groups who developed resistance mutations to elvitegravir in integrase also developed resistance mutations to emtricitabine in RT.
Pri vseh izolatih HIV-1 bolnikov v obeh skupinah zdravljenja, pri katerih so se razvile mutacije, povezane z rezistenco na elvitegravir v integrazi, so se razvile tudi mutacije proti emtricitabinu v RT.

As an integrase inhibitor, raltegravir targets integrase, an HIV enzyme
Raltegravir deluje na encim integrazo, ki omogoča virusu HIV,

regimens, including boosted-PI-, NNRTI-, and integrase inhibitor(INSTI)-based therapies.
NNRTI in zaviralca integraze(INSTI), so bili deleži SVR> 94%.

It blocks an enzyme called integrase, which is involved in the process of the HIV-1 virus's replication,
Ta blokira encim integrazo, ki sodeluje v procesu razmnoževanja virusa HIV-1,

dolutegravir belongs to a group of anti-retroviral medicines called integrase inhibitors(INIs).
v skupino protiretrovirusnih zdravil, ki se imenujejo zaviralci integraze(ZI).

Since the recommended dose of dolutegravir is 50 mg twice daily for patients with resistance to integrase inhibitors, the use of Triumeq is not recommended for patients with integrase inhibitor resistance.
Ker je priporočeni odmerek dolutegravirja pri bolnikih z odpornostjo na zaviralce integraze 50 mg dvakrat dnevno, uporaba zdravila Triumeq pri bolnikih z odpornostjo na zdravila iz skupine zaviralcev integraze ni priporočljiva.

including those with resistance to integrase inhibitors.
odporni proti zaviralcem integraze.

in VIKING-3(not placebo controlled), including by baseline integrase resistance categories.
študiji VIKING-3(nekontrolirani s placebom), vključno z izhodiščnimi kategorijami odpornosti na integrazo.

along with one or more additional integrase mutations.
več dodatnimi mutacijami integraze.

one subject had pre-existing integrase mutations and is assumed to have been integrase experienced or infected with integrase resistant virus by transmission.
je imela že obstoječe mutacije integraze in se predpostavlja, da je predhodno že dobivala zdravila iz skupine zaviralcev integraze ali je bila preko prenosa okužena z virusom, odpornim na integrazo.

Of these four, two subjects had a unique R263K integrase substitution, with a maximum fold change of 1.93,
Od teh štirih sta dva preiskovanca imela edinstveno substitucijo integraze R263K, z maksimalno vrednostjo spremembe občutljivosti 1,93,

N155H/S(n= 2) in integrase.
Q148R(n= 2) in N155H/S(n= 2) v integrazi.

HIV integrase inhibitors in ART-experienced patients.
Inhibitorji HIV integraze pri bolnikih z izkušnjami z ART.

Elvitegravir, an antiretroviral medicine known as an integrase inhibitor.
Elvitegravir, protiretrovirusno zdravilo, znano kot zaviralec integraze.

Elvitegravir-resistant vi uses show varying degrees of cross-resistance to the integrase strand transfer.
A elvitegravir, kažejo različne stopnje navzkrižne rezistence na zaviralca prenosa.

Vitekta was at least as effective as raltegravir(another integrase inhibitor) when taken in combination with other anti-HIV medicines.
najmanj tako učinkovito kot raltegravir(drug zaviralec integraze), če se je jemalo v kombinaciji z drugimi zdravili proti virusu HIV.

There are several integrase inhibitors currently under clinical trial, and raltegravir became the
V kliničnih študijah preskušajo več učinkovin iz te skupine, raltegravir pa je prvi,